Strategic Blueprint’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Strategic Blueprint's IDXX Position: Q2 2026 in Review
Strategic Blueprint increased its Idexx Laboratories (IDXX) stake by 0.44% in Q2 2026, buying an estimated $1.12K and bringing the position to 457 shares worth $241K. The position accounts for 0.01% of the portfolio, ranked #626.
Strategic Blueprint first reported a position in IDXX in Q3 2019 and has held it in 21 quarters since. The position peaked at $412K in Q4 2021. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Strategic Blueprint held 457 shares of Idexx Laboratories worth $241K as of Q2 2026.
- Strategic Blueprint bought 2 Idexx Laboratories shares in Q2 2026, an estimated $1.12K.
- Idexx Laboratories made up 0.01% of Strategic Blueprint's portfolio in Q2 2026, its #626 holding.
- Strategic Blueprint first reported a position in Idexx Laboratories in Q3 2019 and has held it in 21 quarters since.
- Strategic Blueprint's Idexx Laboratories position peaked at $412K in Q4 2021.
- 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Strategic Blueprint's 13F filing for Q2 2026, filed 23 Jul 2026.